Benzinga | Nov 16, 2021 06:01AM EST

NRX Pharmaceuticals Q3 EPS $(0.40) Down From $(0.15) YoY

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.40) per share. This is a 166.67 percent decrease over losses of $(0.15) per share from the same period last year.